Pharmacological advances in addiction treatment (Q39410456)

11 September 2017

1 reference

title

Pharmacological advances in addiction treatment (English)

1 reference

11 September 2017

1 reference

Preston KL

1

1 reference

PubMed ID

2867050

11 September 2017

Bigelow GE

series ordinal

2

1 reference

11 September 2017

1 June 1985

1 reference

11 September 2017

Substance Use and Misuse

1 reference

11 September 2017

20

1 reference

11 September 2017

6-7

1 reference

11 September 2017

845-867

1 reference

l-Acetylmethadol (LAM) treatment of opiate dependence: plasma and urine levels of two pharmacologically active metabolites.

11 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

The Endorphins: A Growing Family of Pharmacologically Pertinent Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the α-antagonist piperoxane

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Acupuncture in heroin addicts; changes in Met-enkephalin and beta-endorphin in blood and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Naltrexone, opiate addiction, and endorphins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Evidence for an endorphin dysfunction in methadone addicts: Lack of ACTH response to naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Heroin addiction. Sequential treatment employing pharmacologic supports

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Endorphins: physiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Analgesic effectiveness of the narcotic agonist-antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Present status of narcotic addiction with particular reference to medical indications and comparative addiction liability of the newer and older analgesic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Liability of addiction to 6-dimethylamino-4-4-diphenyl-3-heptanone (methadon, amidone or 10820) in man; experimental addiction to methadon.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Further experience with methadone in the treatment of narcotics users.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Levomethadyl acetate. Prolonged duration of opioid effects, including cross tolerance to heroin, in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Methadyl acetate and methadone as maintenance treatments for heroin addicts. A veterans administration cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

A clinical, controlled study of l-alpha-acetylmethadol in the treatment of narcotic addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Multiple opioid receptors: a little about their history and some implications related to evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

21 January 2018

Methadone—A Reevaluation

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Buprenorphine suppresses heroin use by heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

α-1-Acetylmethadol and its N-demethylated metabolites have potent opiate action in the guinea pig isolated ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Opiate Receptor: Demonstration in Nervous Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Stereospecific Binding of the Potent Narcotic Analgesic [ 3 H]Etorphine to Rat-Brain Homogenate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Diazepam use among methadone maintenance patients: Patterns and dosages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Search for an Endogenous Ligand for the Opiate Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Effects of clonidine on morphine withdrawal signs in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Some thoughts about opiopeptins, peptides with opiate-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Misuse and Abuse of Diazepam: An Increasingly Common Medical Problem

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Stereospecific Interaction Between Narcotic Analgesics and a Synaptic Plasma Membrane Fraction of Rat Cerebral Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10826088509047756

10.3109/10826088509047756

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference

PubMed ID

2867050